Dazed and confused: A molecular genetic approach to everyday cognitive failure
Introduction
The frequency of every day cognitive failures such as confusing left and right, leaving important letters or emails unanswered for days and forgetting appointments or even people's names varies considerably across people. The Cognitive failure questionnaire (CFQ, [1]) has been developed to measure these individual differences in proneness to slips or errors. The CFQ consists of several brief scenarios that represent perceptual (“Do you fail to notice signposts on the road?”), memory (“Did you forget whether you turned off a light or a fire or locked the door?”) or psychomotor failure (“Did you bump into people?”). Importantly, the scenarios do not aim at failure of ability but at occasional and transient departure from normal functioning. Participants are asked to state on a five-point Likert scale how often the mentioned event happened to them in the past six months.
Validity for the CFQ stems from studies that predict the frequency of every day mishaps and accidents from the CFQ scores. The self-report on the CFQ coincides with the frequency of car accidents [2], [3], injuries from falling [4] and work accidents [2]. Optimized work flow in office jobs is also jeopardized in CFQ-high-scorers as they lose computing work more often because they forget to save it to the hard drive [5]. Furthermore, the CFQ has predictive validity for strain and burden due to occupational stress [6] which highlights the role of cognitive failure susceptibility as a risk factor for aversive conditions at the work place.
Given the relevance of cognitive failure susceptibility for occupational and health related topics, it is of high interest to examine more closely what contributes to individual proneness to cognitive failure. Evidence indicates that cognitive, personality-related and biological variables have an impact on CFQ scores.
Given the proximity of the CFQ's scenarios to situations in which planning skills or focused attention fail, it is not surprising that the CFQ is highly intercorrelated with laboratory measures of executive functioning. People who score low on the CFQ are better at excluding irrelevant distractors from information processing [7], [8], [9], [10] and are more adept at inhibiting preponent yet inappropriate responses [11], [12]. The cognitive deficits associated with high CFQ scores, however, do not extend to general cognitive ability [1], stressing the idea that cognitive failure results from absentmindedness and the failure to deploy attentional resources when appropriate rather than low levels of intellect.
Another source of individual variation is personality. Here, the personality dimension “impulsivity” can predict CFQ scores. Highly impulsive individuals – who tend to react more rapidly or unplanned and with little regard to negative consequences – are more susceptible to cognitive failure [13]. As heightened impulsivity has been linked to various psychopathological conditions, the link with impulsivity might in part account for the role of the CFQ as a clinical assessment tool.
A further perspective on individual differences focuses on biological variables such as genetics. A large family study confirmed a strong genetic influence on the frequency of everyday cognitive failure: additive genetic factors can account for about 50% of the total variance in CFQ scores [14]. This finding is in line with the general notion that executive functioning represents one of the most heritable psychological phenotypes [15].
Given this high heritability, the imperative step in the study of individual differences in proneness to cognitive failures is the identification of genetic variants that impact the CFQ. A promising candidate is the DRD2 gene on the q22-23 strand of chromosome 11 that codes for the dopamine D2 receptor. A common C → T single nucleotide polymorphism (SNP) on this gene is rs6277 (DRD2 c957t). Even though a synonymous nucleotide transition, the functionality of this SNP has been proven by complementary methods in vivo and in vitro [16], [17], [18]. DRD2 rs6277 is in strong linkage disequilibrium with DRD2/ANKK1 Taq Ia (rs1800497), a SNP on the adjacent ANKK1 gene [19]. Literatures have identified rs1800497 as genetic marker for dopamine D2 receptor density [20], [21] but evidence suggests that this association is driven by the mentioned linkage disequilibrium with functional variants on the DRD2 gene such as rs6277 [19], [22]. On the behavioral level, DRD2 rs6277 has been repeatedly associated with measures of executive functioning including working memory [19], [23], [24], [25]. Furthermore, phenotypic associations with impulsivity have been reported [26]. The question which allelic variant is beneficial for cognitive functioning is difficult to answer because directions of reported effects vary, presumably because of interactions with other gene loci [19], [24], [25] or because of different influences on task components [27], [28]. In our work, however, we consistently identified improved cognitive functioning in carriers of the C/C genotype [19], [24], [28]. Given the proof of functionality of DRD2 rs6277 on the cellular and neuronal level and the associations with phenotypes related to the frequency of cognitive failure, it seems plausible to hypothesize an association between the SNP and the CFQ scores as well. Based on our previous findings, we hypothesize reduced failure susceptibility in C/C carriers.
A further issue is the relationship between genetics, personality and cognitive failures. Genes affect the hard-wiring of our brains which represents the biological basis of personality (for review see [29]). It seems plausible that a possible association between DRD2 and the CFQ is mediated by impulsivity: Impulsivity is characterized by aberrations to the mid-brain dopaminergic system resulting in stronger phasic dopamine release in response to novel, rewarding and salient information [30]. Furthermore, trait impulsivity can predict whether an individual's performance in a cognitive control task improves or declines after a pharmacological challenge with dopaminergic agents, indicating that impulsivity reflects an index for base rate dopamine turnaround [31].
Besides from the hypothesis that the rs6277 polymorphism is associated with the CFQ scores we also seek to replicate the observed relationship between DRD2 rs6277 and impulsivity and test whether the relationship between rs6277 and the CFQ is statistically mediated by trait impulsivity.
Section snippets
Participants and measures
A total of N = 500 participants (n = 140 male, n = 360 female, mean age M = 24.62, SD = 7.98) provided buccal swabs for genotyping and filled in the cognitive failure questionnaire after their informed written consent was obtained. We used the German version of the CFQ that contains seven additional scenarios to the 25 scenarios from the English version [32]. Moreover, a large subsample of n = 420 participants (n = 113 male, n = 307 female, mean age M = 24.71, SD = 8.48) filled in the Barratt impulsivity scale
Results
Genotype frequencies for DRD2 rs6277 were as follows: C/C: n = 119, C/T: n = 227, T/T: n = 154 (Test for Hardy–Weinberg equilibrium: χ2(1) = 3.83, n. s.). An analysis of the CFQ's internal consistency revealed an excellent reliability (alpha = .90).
Fig. 1a shows descriptive statistics for the CFQ depending on DRD2 rs6277 on the genotype level. A one-way ANOVA model with the three genotypes as factor levels revealed an influence of DRD2 rs6277 on the CFQ scores (F(2, 499) = 4.553, p = .01). A two-sample t
Discussion
An individual's proneness to cognitive failure as measured by the cognitive failure questionnaire (CFQ) is both a predictor for everyday mishaps with mild to severe consequences and a susceptibility factor for occupational strain and burden. Based on a twin study that highlighted a strong heritable component of the CFQ, we conducted a molecular genetic association study whose aims were twofold: First, we sought to relate individual genetic variants of the rs6277 (C957T) polymorphism in the
References (41)
- et al.
Individual differences in selective attention: the relation of priming and interference to cognitive failure
Personality and Individual Differences
(1987) - et al.
Dissociable executive functions in the dynamic control of behavior: inhibition, error detection, and correction
NeuroImage
(2002) - et al.
The dopamine D2 receptor gene DRD2 and the nicotinic acetylcholine receptor gene CHRNA4 interact on striatal grey matter volume: evidence from a genetic imaging study
NeuroImage
(2013) - et al.
Evidence for the modality independence of the genetic epistasis between the dopaminergic and cholinergic system on working memory capacity
European Neuropsychopharmacology
(2011) - et al.
DRD2 c957t polymorphism interacts with the COMT val158met polymorphism in human working memory ability
Schizophrenia Research
(2007) - et al.
Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity
Neuroscience
(2010) - et al.
The DRD2 C957T polymorphism and the attentional blink—a genetic association study
European Neuropsychopharmacology
(2013) - et al.
Dopamine serotonin and impulsivity
Neuroscience
(2012) - et al.
The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans
Psychiatry Research
(2010) - et al.
The cognitive failures questionnaire (CFQ) and its correlates
British Journal of Clinical Psychology
(1982)